Otsuka Holdings Co., Ltd. (OTSKY)
OTCMKTS · Delayed Price · Currency is USD
25.01
+1.31 (5.53%)
Aug 1, 2025, 3:59 PM EDT
CTI BioPharma Market Cap
Otsuka Holdings has a market cap or net worth of $26.59 billion as of August 1, 2025. Its market cap has increased by 13.81% in one year.
Market Cap
26.59B
Enterprise Value
25.67B
Revenue
16.65B
Ranking
n/a
PE Ratio
9.38
Stock Price
$25.01
Market Cap Chart
Since December 15, 2010, Otsuka Holdings's market cap has increased from 12.15B to 26.59B, an increase of 118.91%. That is a compound annual growth rate of 5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 26.59B | -9.53% |
| Dec 30, 2024 | 29.39B | 44.33% |
| Dec 29, 2023 | 20.36B | 14.95% |
| Dec 30, 2022 | 17.71B | -9.80% |
| Dec 30, 2021 | 19.64B | -15.33% |
| Dec 30, 2020 | 23.19B | -4.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 409.70M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.29M |
| Northwest Biotherapeutics | 351.67M |